Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Acelrx Pharmaceutica (ACRX)
Acelrx Pharmaceutica (ACRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,393
  • Shares Outstanding, K 7,449
  • Annual Sales, $ 2,820 K
  • Annual Income, $ -35,100 K
  • 60-Month Beta 0.27
  • Price/Sales 3.39
  • Price/Cash Flow N/A
  • Price/Book 0.19
Trade ACRX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.54
  • Most Recent Earnings -0.94 on 11/14/22
  • Next Earnings Date 03/30/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 386.51% ( -238.22%)
  • Historical Volatility 110.76%
  • IV Percentile 64%
  • IV Rank 26.95%
  • IV High 1,234.59% on 03/17/23
  • IV Low 73.65% on 11/28/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 33
  • Volume Avg (30-Day) 26
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 1,262
  • Open Int (30-Day) 1,610

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5687 +26.59%
on 03/20/23
1.4500 -50.35%
on 02/27/23
-0.7201 (-50.01%)
since 02/23/23
3-Month
0.5687 +26.59%
on 03/20/23
2.7800 -74.10%
on 01/13/23
-1.3501 (-65.22%)
since 12/23/22
52-Week
0.5687 +26.59%
on 03/20/23
7.6000 -90.53%
on 08/11/22
-5.7721 (-88.91%)
since 03/23/22

Most Recent Stories

More News
AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

ACRX : 0.7199 (-0.57%)
AcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.7199 (-0.57%)
Three Healthcare Penny Stocks to Watch In The New Year

These three penny (and nickel) stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching.

ACRX : 0.7199 (-0.57%)
HAPP : 4.50 (+1.35%)
SLNO : 2.17 (+4.33%)
AcelRx Pharmaceuticals (ACRX) Reports Q3 Loss, Misses Revenue Estimates

AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of 21.67% and 7.82%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

ACRX : 0.7199 (-0.57%)
HARP : 0.6870 (-0.22%)
AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.7199 (-0.57%)
AcelRx to Host Third Quarter 2022 Financial Results Call and Webcast on November 14, 2022

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company, today announced that it will release third quarter...

ACRX : 0.7199 (-0.57%)
AcelRx Pharmaceuticals Announces Presentation of a Large Cohort of Complex Plastic Surgery Procedures Performed with DSUVIA at Plastic Surgery The Meeting 2022

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.7199 (-0.57%)
AcelRx Pharmaceuticals Announces Reverse Stock Split

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.7199 (-0.57%)
AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.7199 (-0.57%)
AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Advanced Niyad™ supply chain development with a focus on obtaining an Emergency Use Authorization in 2023 $0.6 million net revenue in Q2 2022; fifth...

ACRX : 0.7199 (-0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of pain. The Company product candidates comprises: ARX-01 or the Sufentanil NanoTab PCA System; ARX-02 or the Sufentanil NanoTab BTP Management System; and...

See More

Key Turning Points

3rd Resistance Point 1.0510
2nd Resistance Point 0.9659
1st Resistance Point 0.8450
Last Price 0.7199
1st Support Level 0.6390
2nd Support Level 0.5539
3rd Support Level 0.4330

See More

52-Week High 7.6000
Fibonacci 61.8% 4.9140
Fibonacci 50% 4.0844
Fibonacci 38.2% 3.2547
Last Price 0.7199
52-Week Low 0.5687

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar